Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma
Article in Frontiers in Medicine (February 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer
Article in Medical Oncology (December 2022)
Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma
Article in Cancers (August 2022)